People with Parkinson's disease that received a growth factor (GDNF) experienced a 100% improvement in dopamine uptake in a key brain region.
“People with Parkinson's disease that received a growth factor (GDNF) experienced a 100% improvement in dopamine uptake in a key brain region involved in the disease compared to the placebo group which did not experience any change.”